Skip to content

All Sections

Wednesday, March 18th 2026

e-Edition

News
- News
- Crime and Public Safety
- Investigative Reporting
- Election
- Politics
- Health
- Environment
- Business
- Best Reviews
- Housing
- Jobs
- Weather
- Transportation
Local News
Sports
- Sports
- IE Varsity
- Chargers
- Rams
- Lakers
- Clippers
- Dodgers
- Angels
- College Sports
- UCLA Sports
- USC Sports
- Kings
- Ducks
- Olympics
- Boxing/MMA
- Soccer
- Horse Racing
Things To Do
Obituaries
Opinion
SCNG Premium
Sponsored Content
The T.E.A.
Branded Content
- Paid Content by Brandpoint
Subscribe
Sun Store
Log In
Logout

Get the latest news delivered daily!

Subscribe
Log In

Account Settings Contact Us Log Out

Spoof a user

Get the latest news delivered daily!

Subscribe
Log In

San Bernardino Sun

Wednesday, March 18th 2026

e-Edition

News
Local News
Sports
Things to Do
Obituaries
Opinion
The T.E.A.

Trending:

Vote for Readers Choice Awards
Iran news
Deputy accused of sexual battery
Weather news
Immigration news
Lent restaurant offerings 🐟

Create Watchlist

Nasdaq Composite

Markets:

News

ClearPoint Neuro Inc. - Common Stock (NQ:CLPT)

9.695 -1.465 (-13.13%)

Streaming Delayed Price Updated: 11:54 AM EDT, Mar 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about ClearPoint Neuro Inc. - Common Stock

News headline image

ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results

March 17, 2026

Via ACCESS Newswire

News headline image

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026

March 06, 2026

Via ACCESS Newswire

News headline image

ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue

January 12, 2026

Via ACCESS Newswire

News headline image

ClearPoint Neuro Completes Acquisition of IRRAS

November 20, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro Reports Third Quarter 2025 Results

November 06, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro Announces Agreement to Acquire IRRAS

November 06, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results

February 26, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain

November 13, 2024

News headline image

ClearPoint Neuro Reports Third Quarter 2024 Results

November 07, 2024

News headline image

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025

November 05, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles

October 07, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide

October 06, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System

October 01, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer

September 25, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024

October 31, 2024

News headline image

ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners

September 04, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro Reports Second Quarter 2025 Results

August 12, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio

August 04, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025

July 23, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro Reports First Quarter 2025 Results

May 13, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing

May 12, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI

April 28, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025

April 25, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 – Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room

April 24, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025

February 14, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula

February 12, 2025

Via ACCESS Newswire

News headline image

ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0

January 27, 2025

Via ACCESS Newswire

ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery

May 24, 2023

From ClearPoint Neuro, Inc.

Via GlobeNewswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.

Subscribe
Contact Us
About San Bernardino Sun
Marketplace
Advertising Solutions
Reader Rewards
Subscribe Now

Terms of Use
Cookie Policy
Cookie Preferences
California Notice at Collection
Notice of Financial Incentive
Do Not Sell/Share My Personal Information
Arbitration
Powered by WordPress.com VIP

Copyright 2026 San Bernardino Sun. All rights reserved. The use of any content on this website for the purpose of training artificial intelligence systems, algorithms, machine learning models, text and data mining, or similar use is strictly prohibited without explicit written consent.